Join this Mental Health Month webinar exploring the latest options for treatment-resistance depression.

Designed for GPs and allied health professionals, this session will unpack practical strategies, novel interventions – including neurostimulation, psychedelics, and ketamine – and referral pathways to support patients who haven’t responded to standard care.

Learn how to navigate complex cases with confidence and discover new pathways to care when conventional treatments fall short.

What to Expect:

1. An overview of current options for treatment-resistant depression and the latest research breakthroughs.
2. Insights into the evolving role of ECT as an effective tool for severe depression.
3. A closer look at ketamine treatment and how it can be integrated with psychotherapy.
4. Discussion of psilocybin and other novel therapeutics in the psychiatric pipeline.
5. An introduction to Black Dog Institute’s comprehensive training offerings in neuromodulation, ketamine, and interventional psychiatry for health professionals.

Facilitator:

Dr Sarah Barker, Clinical Psychologist

Panelists:

Dr Adam Bayes, Senior Research Fellow and Clinical Academic Psychiatrist, Black Dog Institute

Dr Melanie Babooram, Clinical Psychologist, Black Dog Institute

This webinar is designed for GPs, GP registrars, psychologists, and allied mental health practitioners, or any other health professional with an interest in improving outcomes for patients with mental health conditions.

RACGP CPD Accredited Activity – 1 CPD hour (Educational Activities)